Background and Purpose: Possible effects of changes in blood pressure on the cerebral circulation were studied in patients with chronic stroke and age-matched nonstroke control subjects at 28±10 months (mean+SD) (range, 18 to 54 months) and 27±6 months (range, 19 to 44 months), respectively, after the first measurement.
C erebral blood flow (CBF) has prognostic significance in chronic stroke,1-3 reflecting the extension or severity of vascular lesions of the brain.124-6 Mean levels of CBF remain virtually unchanged in many cases despite improvement of clinical symptoms7,8 and electroencephalographic findings.8 '9 Among patients with chronic stroke, cerebral circulatory reserves may be reduced in some cases because of diffuse vascular changes. By monitoring CBF, the early detection of CBF declines should predict deterioration of symptoms or recurrence of stroke.
Hypertension is the most important of all stroke risk factors. Although it remains controversial whether or not a consistent J-shaped relation exists between blood pressure levels and morbidity or mortality from stroke, in the elderly stroke mortality tends to increase when systolic blood pressure is lowered to below 120 mm Hg'0 or 137 mm Hg.1" These critical levels of blood pressure have usually been based on analysis of initial or past levels of blood pressures, and the data of present or prospective levels of blood pressure or changes in blood pressure from initial levels were not described. In clinical practice, levels of blood pressure often vary from initial levels during chronic antihypertensive therapy or even in the untreated condition.
The purpose of the present study was to determine factors that influence changes in CBF among patients with chronic stroke. Possible effects of changes in blood pressure, age, sex, and hematocrit on CBF were evaluated. ries an error of 10% to 15%.14 Blood pressure changes in patients with brain infarction with decreased, unchanged, and increased CBF were analyzed by ANOVA and Scheffe's test. Differences were considered significant when the probability value was less than .05.
Subjects and Methods

Results
The characteristics of the 55 stroke patients and 10 control subjects are displayed in Table 1 . Hypertension was observed in 89% of stroke patients and 70% of control subjects. The percentage of patients who received antihypertensive drug therapy at the first measurement was 14% for those with subcortical infarction and 12% for those with cortical infarction; in comparison, 56% of patients with brain hemorrhage were treated (P<.01). The level of blood pressure, however, did not differ among the four groups. During the follow-up period, no deterioration of clinical outcome or recurrence of stroke was observed. Average values for blood pressure did not change from the first measurement in control subjects and in stroke patients except for the group with cortical infarction, in which diastolic and mean arterial blood pressures significantly decreased by 7 mm Hg and 6 mm Hg, respectively, while average CBF was not reduced (Table 1) .
At the time of the first measurement, the average CBF within the ipsilateral hemisphere was 57±11 mL/ subjects (-1.8 and -1.6 mL/100 g per minute per year in the left and right hemisphere, respectively) as well as in patients with subcortical infarction (-0.61 and -0.60 mL/100 g per minute per year in the ipsilateral and contralateral hemisphere, respectively). By longitudinal analysis, reductions in CBF in both hemispheres were not significant among control subjects or in patients with subcortical infarction. In 10 control subjects, CBF within right and left hemispheres inversely correlated with hematocrit (P=.0212 and P=.0334, respectively). At the time of the second measurement, the average CBF in both hemispheres was unchanged from that of the first measurement among the four groups (Table 1) . A positive correlation was obtained between CBF and mean and/or systolic arterial blood pressure within both the ipsilateral and contralateral hemispheres in the 39 patients with chronic brain infarction (Figs la and lb) and between CBF within the ipsilateral hemisphere and diastolic blood pressure (Fig lc) .
The changes in CBF correlated well with changes in mean and systolic arterial blood pressures in the 39 patients with chronic brain infarction (Figs 2a and 2b) . The similar correlation was also significant in 17 patients with cortical infarction. If the patient whose CBF in the ipsilateral hemisphere decreased by 21 mL/100 g per minute is excluded, the relation between change in mean arterial blood pressure and change in CBF in the ipsilateral hemisphere was still significant (P=.0315); however, the relations between change in mean arterial blood pressure and change in CBF in the contralateral hemisphere or between the change in systolic blood pressure and change in CBF were not significant. In patients with brain hemorrhage or control subjects, there were no correlations between changes in blood pressure and CBF observed in either of the two hemispheres. In control subjects, CBF within the right hemisphere decreased with the increase of hematocrit (P-.025), but the correlation was not significant when one patient whose CBF decreased by 23 mL/100 g per minute was excluded. In 10 patients whose CBF decreased more than 15% compared with initial levels, systolic, diastolic, and mean arterial blood pressure decreased significantly by 24, 12, and 16 mm Hg (mean values), respectively (P<.05, P<.005, and P<.005, respectively; Table 2 ). In 19 patients with unchanged CBF or 10 with increased CBF of more than 15%, the levels of blood pressure did not change ( Table 2, Fig 3) . Changes in systolic and mean arterial blood pressure in patients with decreased CBF were -25+32 mm Hg (range, -90 to 8 mm Hg) and -16±14 mm Hg (range, -49 to 1 mm Hg), respectively ( Table 2, Fig 3) , which were significantly greater than those of other two subgroups: 0±19 mm Hg (range, -28 to 40 mm Hg) and -2±12 mmHg (range, -19 to 32 mm Hg) in patients with unchanged CBF, or 3±22 mm Hg (range, -32 to 26 mm Hg) and -1±11 mm Hg (range, -16 to 15 mm Hg) in patients with increased CBF. In patients with unchanged or increased CBF, levels of systolic blood pressure were all maintained above 110 mm Hg at the second measurement, and changes in systolic and mean arterial blood pressure did not fall below -20% and -16%, respectively ( Table 2) . Discussion Main results of our study were the following: (1) changes in CBF correlated well with changes in systolic and mean arterial blood pressures in 39 patients with chronic cerebral infarction; (2) of these, in 10 patients whose CBF decreased more than 15%, systolic and mean arterial blood pressure significantly decreased by 25 mm Hg and 16 mm Hg (mean values), respectively; and (3) in 29 patients with unchanged or increased CBF, levels of systolic and mean arterial blood pressure did not significantly change, and decreases in systolic and mean arterial blood pressure did not exceed 32 mm Hg (20% decrease) and 19 mm Hg (16% decrease), respectively. All levels of systolic blood pressure were maintained above 110 mm Hg.
Stroke affects mainly the elderly, and 67% of our stroke patients and 80% of our control subjects were older than age 60 years at the time of the second measurement. In the control subjects and patients with subcortical infarction, age-related reductions in CBF were observed at the time of the first study, which was compatible with previous reports.15 "16 However, we have preliminarily assessed relations between changes in CBF and blood pressure, and additional further longitudinal observations of changes in CBF, blood pressure, and neurological prognosis will be required.
In patients with chronic cerebral hemorrhage, there were no correlations between changes in blood pressure and CBF. The younger age of these patients compared with those with cerebral infarctions and milder arteriosclerotic changes may, in part, explain these autoregulatory differences between patients with cerebral infarction and those with cerebral hemorrhage. In control subjects, CBF was maintained constant despite the changes in blood pressure, confirming that vascular functions for autoregulatory adaptation in nonstroke patients, as expected, are well preserved compared with those in stroke patients.
In our patients, CBF data at the first measurement were obtained at more than 1 month after the stroke to avoid the management difficulties frequently encountered during the acute stage and the interference of brain edema or intracranial hypertension. In most of our patients, brain edema is felt to resolve within the first 4 weeks after cerebral hemorrhage by the findings of follow-up CT scans and stabilized neurological deficit, and there may be little effect of perihematoma edema on CBF data at the time of first measurement. Blood viscosity is mainly dependent on hematocrit24 and serum fibrinogen values,25 and among our control subjects hematocrit appears to the another possible factor that predicts changes in CBF. Among our patients with brain infarction, however, the change in hematocrit was not correlated with changes in CBF or blood pressure. Therefore, our data suggest that changes in CBF correlate with changes in blood pressure independent of change in hematocrit in chronic cerebral infarction.
Changes in blood pressure emerge as an important factor influencing CBF among patients with chronic brain infarction. It is suggested, therefore, that when antihypertensive treatment is initiated, careful follow-up is required to safeguard the systolic blood pressure from being lowered below critical levels among patients with chronic cerebral infarction.
